Crinetics Pharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Crinetics Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2015 to Q4 2023.
  • Crinetics Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $6.95M, a 69% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $6.95M +$2.84M +69% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $4.11M +$2.56M +165% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $1.55M +$461K +42.2% Dec 31, 2021 10-K 2024-02-28
Q4 2020 $1.09M +$206K +23.3% Dec 31, 2020 10-K 2024-02-28
Q4 2019 $886K +$542K +158% Dec 31, 2019 10-K 2023-02-28
Q4 2018 $344K +$185K +116% Dec 31, 2018 10-K 2022-03-30
Q4 2017 $159K +$91K +134% Dec 31, 2017 10-K 2021-03-30
Q4 2016 $68K +$68K Dec 31, 2016 10-K 2020-03-09
Q4 2015 $0 Dec 31, 2015 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.